BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

48 related articles for article (PubMed ID: 38730335)

  • 1. Identification of the molecular subtypes and signatures to predict the prognosis, biological functions, and therapeutic response based on the anoikis-related genes in colorectal cancer.
    Zhai X; Chen B; Hu H; Deng Y; Chen Y; Hong Y; Ren X; Jiang C
    Cancer Med; 2024 May; 13(10):e7315. PubMed ID: 38785271
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comprehensive analysis of the relationship between ubiquitin-specific protease 21 (USP21) and prognosis, tumor microenvironment infiltration, and therapy response in colorectal cancer.
    Nie H; Yu Y; Wang F; Huang X; Wang H; Wang J; Tao M; Ning Y; Zhou J; Zhao Q; Xu F; Fang J
    Cancer Immunol Immunother; 2024 Jun; 73(8):156. PubMed ID: 38834869
    [TBL] [Abstract][Full Text] [Related]  

  • 3. ADAMTSL2 is a potential prognostic biomarker and immunotherapeutic target for colorectal cancer: Bioinformatic analysis and experimental verification.
    Huang Z; Hu X; Wei Y; Lai Y; Qi J; Pang J; Huang K; Li H; Cai P
    PLoS One; 2024; 19(5):e0303909. PubMed ID: 38814950
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Breast cancer clinical outcomes and tumor immune microenvironment: cross-dialogue of multiple epigenetic modification profiles.
    Teng C; Song X; Fan C; Man S; Hu Y; Hou Y; Xin T
    Aging (Albany NY); 2024 May; 16(10):8998-9022. PubMed ID: 38796789
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Establishment of a neutrophil extracellular trap-related prognostic signature for colorectal cancer liver metastasis and expression validation of CYP4F3.
    Tang XL; Xu ZY; Guan J; Yao J; Tang XL; Zhou ZQ; Zhang ZY
    Clin Exp Med; 2024 May; 24(1):112. PubMed ID: 38795162
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A novel Senescence-Based prognostic model unveils tumor interactions and drug resistance in colorectal cancer.
    Yue Y; She X; Ding W; Chen S; Xiao Q; Pan B; Zhou L; Yin Y; Li Y; Wang S; Xu M
    Int Immunopharmacol; 2024 Jun; 134():112197. PubMed ID: 38733826
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of DNA methylation characteristics associated with metastasis and prognosis in colorectal cancer.
    Qian F; Li Q; Chang H; Wei K; Chen X; Huang T; Li Y
    BMC Med Genomics; 2024 May; 17(1):127. PubMed ID: 38730335
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Zinc Finger Proteins: Functions and Mechanisms in Colon Cancer.
    Liu S; Sima X; Liu X; Chen H
    Cancers (Basel); 2022 Oct; 14(21):. PubMed ID: 36358661
    [TBL] [Abstract][Full Text] [Related]  

  • 9. DNA methylation regulator-mediated modification pattern defines tumor microenvironment immune infiltration landscape in colon cancer.
    Yuan S; Gao Y; Xia Y; Wang Z; Wang X
    Front Genet; 2022; 13():1008644. PubMed ID: 36276973
    [TBL] [Abstract][Full Text] [Related]  

  • 10. DNA methylation regulator-mediated modification patterns and tumor microenvironment characterization in glioma.
    Luo H; Ye M; Hu Y; Wu M; Cheng M; Zhu X; Huang K
    Aging (Albany NY); 2022 Sep; 14(19):7824-7850. PubMed ID: 36152044
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The cAMP/PKA/CREB and TGFβ/SMAD4 Pathways Regulate Stemness and Metastatic Potential in Colorectal Cancer Cells.
    Fujishita T; Kojima Y; Kajino-Sakamoto R; Mishiro-Sato E; Shimizu Y; Hosoda W; Yamaguchi R; Taketo MM; Aoki M
    Cancer Res; 2022 Nov; 82(22):4179-4190. PubMed ID: 36066360
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Chemokines in colon cancer progression.
    Jia SN; Han YB; Yang R; Yang ZC
    Semin Cancer Biol; 2022 Nov; 86(Pt 3):400-407. PubMed ID: 35183412
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A Pan-Cancer Analysis of Predictive Methylation Signatures of Response to Cancer Immunotherapy.
    Xu B; Lu M; Yan L; Ge M; Ren Y; Wang R; Shu Y; Hou L; Guo H
    Front Immunol; 2021; 12():796647. PubMed ID: 34956232
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Interaction Between Macrophage Extracellular Traps and Colon Cancer Cells Promotes Colon Cancer Invasion and Correlates With Unfavorable Prognosis.
    Chen T; Wang Y; Nan Z; Wu J; Li A; Zhang T; Qu X; Li C
    Front Immunol; 2021; 12():779325. PubMed ID: 34925357
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Novel Methylation Biomarkers for Colorectal Cancer Prognosis.
    Gutierrez A; Demond H; Brebi P; Ili CG
    Biomolecules; 2021 Nov; 11(11):. PubMed ID: 34827720
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Neutrophil Extracellular Traps in Colorectal Cancer Progression and Metastasis.
    Khan U; Chowdhury S; Billah MM; Islam KMD; Thorlacius H; Rahman M
    Int J Mol Sci; 2021 Jul; 22(14):. PubMed ID: 34298878
    [TBL] [Abstract][Full Text] [Related]  

  • 17. INHBA promotes the proliferation, migration and invasion of colon cancer cells through the upregulation of VCAN.
    Guo J; Liu Y
    J Int Med Res; 2021 Jun; 49(6):3000605211014998. PubMed ID: 34130530
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of DNA methylation biomarkers for risk of liver metastasis in early-stage colorectal cancer.
    Li W; Guo L; Tang W; Ma Y; Wang X; Shao Y; Zhao H; Ying J
    Clin Epigenetics; 2021 Jun; 13(1):126. PubMed ID: 34108011
    [TBL] [Abstract][Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.